Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protocol HKT-500-US12: A Randomized, Multicenter, Double-Blind, Single Dose Study of the Analgesic Properties of HKT-500 and Placebo in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee

NCT00647231 is registered in ClinicalTrials.gov with Hisamitsu Pharmaceutical Co., Inc. as lead sponsor.

NCT NCT00647231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00647231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protocol HKT-500-US12: A Randomized, Multicenter, Double-Blind, Single Dose Study of the Analgesic Properties of HKT-500 and Placebo in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee
Lead sponsor
Hisamitsu Pharmaceutical Co., Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2008
Completion date
August 31, 2008
Enrollment
300 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee